Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.
Journal
The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
28
8
2020
medline:
28
8
2020
entrez:
27
8
2020
Statut:
ppublish
Résumé
Severe COVID-19 has a high mortality rate. Comprehensive pathological descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the histopathological findings and viral tropism in patients who died of severe COVID-19. In this case series, patients were considered eligible if they were older than 18 years, with premortem diagnosis of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 listed clinically as the direct cause of death. Between March 1 and April 30, 2020, full post-mortem examinations were done on nine patients with confirmed COVID-19, including sampling of all major organs. A limited autopsy was done on one additional patient. Histochemical and immunohistochemical analyses were done, and histopathological findings were reported by subspecialist pathologists. Viral quantitative RT-PCR analysis was done on tissue samples from a subset of patients. The median age at death of our cohort of ten patients was 73 years (IQR 52-79). Thrombotic features were observed in at least one major organ in all full autopsies, predominantly in the lung (eight [89%] of nine patients), heart (five [56%]), and kidney (four [44%]). Diffuse alveolar damage was the most consistent lung finding (all ten patients); however, organisation was noted in patients with a longer clinical course. We documented lymphocyte depletion (particularly CD8-positive T cells) in haematological organs and haemophagocytosis. Evidence of acute tubular injury was noted in all nine patients examined. Major unexpected findings were acute pancreatitis (two [22%] of nine patients), adrenal micro-infarction (three [33%]), pericarditis (two [22%]), disseminated mucormycosis (one [10%] of ten patients), aortic dissection (one [11%] of nine patients), and marantic endocarditis (one [11%]). Viral genomes were detected outside of the respiratory tract in four of five patients. The presence of subgenomic viral RNA transcripts provided evidence of active viral replication outside the respiratory tract in three of five patients. Our series supports clinical data showing that the four dominant interrelated pathological processes in severe COVID-19 are diffuse alveolar damage, thrombosis, haemophagocytosis, and immune cell depletion. Additionally, we report here several novel autopsy findings including pancreatitis, pericarditis, adrenal micro-infarction, secondary disseminated mucormycosis, and brain microglial activation, which require additional investigation to understand their role in COVID-19. Imperial Biomedical Research Centre, Wellcome Trust, Biotechnology and Biological Sciences Research Council.
Sections du résumé
BACKGROUND
Severe COVID-19 has a high mortality rate. Comprehensive pathological descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the histopathological findings and viral tropism in patients who died of severe COVID-19.
METHODS
In this case series, patients were considered eligible if they were older than 18 years, with premortem diagnosis of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 listed clinically as the direct cause of death. Between March 1 and April 30, 2020, full post-mortem examinations were done on nine patients with confirmed COVID-19, including sampling of all major organs. A limited autopsy was done on one additional patient. Histochemical and immunohistochemical analyses were done, and histopathological findings were reported by subspecialist pathologists. Viral quantitative RT-PCR analysis was done on tissue samples from a subset of patients.
FINDINGS
The median age at death of our cohort of ten patients was 73 years (IQR 52-79). Thrombotic features were observed in at least one major organ in all full autopsies, predominantly in the lung (eight [89%] of nine patients), heart (five [56%]), and kidney (four [44%]). Diffuse alveolar damage was the most consistent lung finding (all ten patients); however, organisation was noted in patients with a longer clinical course. We documented lymphocyte depletion (particularly CD8-positive T cells) in haematological organs and haemophagocytosis. Evidence of acute tubular injury was noted in all nine patients examined. Major unexpected findings were acute pancreatitis (two [22%] of nine patients), adrenal micro-infarction (three [33%]), pericarditis (two [22%]), disseminated mucormycosis (one [10%] of ten patients), aortic dissection (one [11%] of nine patients), and marantic endocarditis (one [11%]). Viral genomes were detected outside of the respiratory tract in four of five patients. The presence of subgenomic viral RNA transcripts provided evidence of active viral replication outside the respiratory tract in three of five patients.
INTERPRETATION
Our series supports clinical data showing that the four dominant interrelated pathological processes in severe COVID-19 are diffuse alveolar damage, thrombosis, haemophagocytosis, and immune cell depletion. Additionally, we report here several novel autopsy findings including pancreatitis, pericarditis, adrenal micro-infarction, secondary disseminated mucormycosis, and brain microglial activation, which require additional investigation to understand their role in COVID-19.
FUNDING
Imperial Biomedical Research Centre, Wellcome Trust, Biotechnology and Biological Sciences Research Council.
Identifiants
pubmed: 32844161
doi: 10.1016/S2666-5247(20)30115-4
pii: S2666-5247(20)30115-4
pmc: PMC7440861
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e245-e253Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2016-07-012
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Informations de copyright
© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Références
Am J Pathol. 1983 Jul;112(1):112-26
pubmed: 6859225
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Virchows Arch. 2020 Jun;476(6):821-823
pubmed: 32350596
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Br J Haematol. 2020 Jun;189(6):1062-1063
pubmed: 32369628
Ann Intern Med. 2020 May 5;172(9):629-632
pubmed: 32163542
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
Intensive Care Med. 2020 Jun;46(6):1124-1126
pubmed: 32328726
Infect Dis Poverty. 2020 Apr 28;9(1):45
pubmed: 32345362
Mod Pathol. 2020 Jun;33(6):1007-1014
pubmed: 32291399
Clin Microbiol Infect. 2020 Oct;26(10):1428-1429
pubmed: 32502643
J Thromb Haemost. 2020 Jun;18(6):1517-1519
pubmed: 32294295
Am J Clin Pathol. 2020 May 5;153(6):725-733
pubmed: 32275742
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32412897
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
J Clin Pathol. 2020 May;73(5):239-242
pubmed: 32198191
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098
pubmed: 32361738
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet Respir Med. 2013 Jul;1(5):395-401
pubmed: 24429204
Int J Pancreatol. 1988 May;3(4):273-81
pubmed: 2455008
N Engl J Med. 2020 Sep 3;383(10):989-992
pubmed: 32530583
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Am J Pathol. 2007 Apr;170(4):1136-47
pubmed: 17392154
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651